ConductScience.org, home

Gene · 4938

Papers3,817

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

81 to 100 of 3,817

Download this page as JSON
TitleJournalYearPMIDFound bySource
The radiotherapy induced cyclic GMP-AMP-synthase re-localization and immune signature predicts HNSCC treatment efficacy.Commun Med (Lond)202641545483PubTator, text miningPubMed
Causal splicing variants revealed by deep-learning integration of single-cell sQTL mapping under influenza infection.Res Sq202641542048PubTator, text miningPubMed
Exploration of shared gene signatures and molecular mechanisms between psoriasis and COVID-19: evidence from transcriptome data.Mamm Genome202641530290PubTator, text miningPubMed
The OAS-RNase L pathway: Insights from experiments of nature.Sci Immunol202641512080PubTator, text miningPubMed
Human Coronavirus 229E May Infect Human Lung Vascular Endothelium and Induce Delayed Inflammatory and Antiviral Response.APMIS202641510575PubTator, text miningPubMed
Protective effects of Prunella vulgaris polysaccharides against herpes simplex virus type 1 infection through the STING-TBK1-IRF3 pathway.J Integr Med202641506946PubTator, text miningPubMed
Lithocholic acid exerts antiviral activity against porcine epidemic diarrhea virus by enhancing TGR5-mediated type III interferon production.Microb Pathog202641242567PubTator, text miningPubMed
Integrated multi-omics and molecular docking reveal shared molecular mechanisms of Helicobacter pylori infection and rheumatic diseases.Int J Surg202641217343PubTator, text miningPubMed
Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107.Mol Oncol202641216708PubTator, text miningPubMed
Intersection of COVID-19 and Alzheimer's Disease: Genetic Insights and Neuropathological Consequences.Biochem Genet202640720045PubTator, text miningPubMed
The strategies and advances of mRNA translation booster.Asian J Pharm Sci202541809895PubTator, text miningPubMed
Targeting Impaired Type I Interferon-IL-27 Signaling Rescues T Regulatory Cell Suppressive Function in Relapsing-Remitting Multiple Sclerosis.bioRxiv202541783369PubTator, text miningPubMed
A novel prognostic model based on epithelial cell progression genes identifies OAS1 as a suppressor of bladder cancer aggressiveness.Front Mol Biosci202541584451PubTator, text miningPubMed
Large-Scale Gene-Smoking Interactions and Fine Mapping Study Identifies Multiple Novel Blood Pressure Loci in over 1 Million Individuals.medRxiv202541480028PubTator, text miningPubMed
Modulation of TLR7, TYK2 and OAS1 expression during SARS-CoV-2 infection.Front Immunol202541445728PubTator, text miningPubMed
OAS1 and OAS3 genetic variants enhance inflammatory responses to SARS-CoV-2.iScience202541438061PubTator, text miningPubMed
DENetwork unveils non-differentially expressed genes with functional relevance across conditions through information flow perturbation.Nucleic Acids Res202541404797PubTator, text miningPubMed
Comparison of human cerebral organoids infected with wild-type Zika versus attenuated DN-2 virus strains uncovers differences in host immune responses.Cell Commun Signal202541398675PubTator, text miningPubMed
Advancement of a Physiologically Relevant 3D Lung Model through One-Stage DLP Bioprinting for the Study of Lung Diseases.ACS Appl Mater Interfaces202541358540PubTator, text miningPubMed
Analysis of immune-related genes and potential therapeutic drugs in refractory lupus nephritis: Comparison with drug-sensitive lupus nephritis based on RNA transcription data.Medicine (Baltimore)202541327692PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/4938/papers?page=5